%PDF-1.7
%
1 0 obj
<>
endobj
185 0 obj
<>/Font<>>>/Fields 190 0 R>>
endobj
186 0 obj
<>stream
application/pdf
Clauber
(S40 V - M\351dico Infectologista...)
2012-05-10T14:22:19
PScript5.dll Version 5.2.2
2013-03-09T16:11:30-03:00
2013-03-09T16:11:30-03:00
Gnostice PDFtoolkit V2.02
uuid:df2e1b3f-2dfc-4951-a999-719a6c789474
uuid:e05e12f8-1e17-48d2-a8e9-a8d9af7dba42
endstream
endobj
3 0 obj
<>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/Type/Page>>
endobj
118 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
133 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
138 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
143 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
148 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
153 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
158 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
163 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/Type/Page>>
endobj
170 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
175 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
222 0 obj
<>stream
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
/GS0 gs
q 1 0 0 1 2448.3601 437.18 cm
0 0 m
59.78 0 l
87.18 0 109.6 -23.797 109.6 -52.887 c
109.6 -65.223 l
109.6 -94.313 87.18 -118.11 59.78 -118.11 c
0 -118.11 l
-27.4 -118.11 -49.82 -94.313 -49.82 -65.223 c
-49.82 -52.887 l
-49.82 -23.797 -27.4 0 0 0 c
h
S
Q
Q
BT
0 0 0 1 k
/GS0 gs
/T1_0 11 Tf
1 0 0 1 293.8479 41.9695 Tm
(11)Tj
ET
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
q 1 0 0 1 2479.1599 6638.48 cm
0 0 m
-0.77 -6162.125 l
S
Q
Q
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
q 1 0 0 1 2597.0701 378.672 cm
0 0 m
2125.72 0 l
S
Q
Q
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
q 1 0 0 1 234.453 378.66 cm
0 0 m
2125.717 0 l
S
Q
Q
BT
/T1_0 9 Tf
1 0 0 1 350.1119 36.9572 Tm
(FUNCAB - Funda\347\343o Professor Carlos Augusto Bittencourt)Tj
/T1_0 11 Tf
-315.9 749.204 Td
(Quest\343o 45)Tj
0 -336.378 TD
(Quest\343o 47)Tj
283.499 336.378 Td
(Quest\343o 49)Tj
ET
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
q 1 0 0 1 777.219 6579.4302 cm
0 0 m
1580.421 0 l
S
Q
Q
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
q 1 0 0 1 777.223 3776.28 cm
0 0 m
1580.417 0 l
S
Q
Q
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
q 1 0 0 1 3139.71 6579.4302 cm
0 0 m
1580.42 0 l
S
Q
Q
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
q 1 0 0 1 285.465 6638.48 cm
0 0 m
442.203 0 l
469.457 0 491.754 -22.83 491.754 -50.74 c
491.754 -67.36 l
491.754 -95.27 469.457 -118.1 442.203 -118.1 c
0 -118.1 l
-27.254 -118.1 -49.551 -95.27 -49.551 -67.36 c
-49.551 -50.74 l
-49.551 -22.83 -27.254 0 0 0 c
h
S
Q
Q
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
q 1 0 0 1 285.473 3835.3301 cm
0 0 m
442.199 0 l
469.453 0 491.75 -22.83 491.75 -50.74 c
491.75 -67.37 l
491.75 -95.28 469.453 -118.11 442.199 -118.11 c
0 -118.11 l
-27.258 -118.11 -49.555 -95.28 -49.555 -67.37 c
-49.555 -50.74 l
-49.555 -22.83 -27.258 0 0 0 c
h
S
Q
Q
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
q 1 0 0 1 2647.96 6638.48 cm
0 0 m
442.2 0 l
469.45 0 491.75 -22.83 491.75 -50.74 c
491.75 -67.36 l
491.75 -95.27 469.45 -118.1 442.2 -118.1 c
0 -118.1 l
-27.26 -118.1 -49.55 -95.27 -49.55 -67.36 c
-49.55 -50.74 l
-49.55 -22.83 -27.26 0 0 0 c
h
S
Q
Q
BT
/T1_1 11 Tf
1 0 0 1 28.1494 760.6147 Tm
[(U)-52(m)-52(a)-886(p)-52(a)-52(c)-52(i)-52(e)-52(n)-52(t)-52(e)-886(H)-52(I)-52(V)-52(+)-52(,)-885(v)-52(i)-52(r)-52(g)-52(e)-52(m)-886(d)-52(e)-886(t)-52(r)-52(a)-52(t)-52(a)-52(m)-52(e)-52(n)-52(t)-52(o)]TJ
0 -12.288 TD
[(a)-3(n)-3(t)-3(i)-3(r)-3(r)-3(e)-3(t)-3(r)-3(o)-3(v)-3(i)-3(r)-3(a)-3(l)-3(,)-837(m)-3(a)-3(s)-837(c)-3(o)-3(m)-837(i)-3(n)-3(d)-3(i)-3(c)-3(a)-3(\347)-3(\343)-3(o)-837(d)-3(e)-837(i)-3(n)-3(i)-3(c)-3(i)-3(\341)-3(-)-3(l)-3(o)-3(,)]TJ
T*
[(apresenta)-564(contagem)-564(de)-563(c\351lulas)-564(CD4+)-564(maior)-564(que)]TJ
T*
[(250/mm\263.)-402(Neste)-402(caso,)-402(mais)-402(certamente)-402(dever\341)-402(ser)]TJ
T*
[(evitado)-167(o)-167(uso)-167(de:)]TJ
0 -24.577 TD
[(A\))-478(abacavir)54(.)]TJ
0 -12.288 TD
[(B\))-478(atazanavir)54(.)]TJ
T*
[(C\))-423(nevirapina.)]TJ
T*
[(D\))-423(lopinavir/ritonavir)54(.)]TJ
T*
[(E\))-478(zidovudina+lamivudina.)]TJ
0 -213.495 TD
[(No)-456(dengue,)-457(segundo)-457(a)-456(classifica\347\343o)-457(de)-456(gravidade)]TJ
0 -12.288 TD
[(adotada)-378(entre)-377(n\363s)-377(pelo)-377(Minist\351rio)-378(da)-377(Sa\372de,)-377(o)-377(que)]TJ
T*
[(melhor)-167(define)-167(os)-167(grupos)-167(C)-167(e)-167(D)-167(\351)-167(a:)]TJ
0 -24.577 TD
[(A\))-478(prova)-167(do)-167(la\347o)-167(positiva.)]TJ
0 -12.288 TD
[(B\))-478(presen\347a)-168(de)-167(exantema)-167(petequial.)]TJ
T*
[(C\))-423(presen\347a)-168(de)-167(algum)-167(sinal)-167(de)-167(alarme.)]TJ
T*
[(D\))-423(o)-17(c)-17(o)-17(r)-17(r)-17(\352)-17(n)-17(c)-17(i)-17(a)-851(d)-17(e)-851(d)-17(o)-17(i)-17(s)-850(o)-17(u)-851(m)-17(a)-17(i)-17(s)-850(e)-17(p)-17(i)-17(s)-17(\363)-17(d)-17(i)-17(o)-17(s)-850(d)-17(e)]TJ
16.254 -12.288 Td
(epistaxes.)Tj
-16.254 -12.288 Td
[(E\))-478(persist\352ncia)-324(de)-324(febre)-324(acima)-324(de)-324(37.8)-324(\260C)-323(por)-324(mais)]TJ
16.254 -12.288 Td
[(de)-167(tr\352s)-167(dias.)]TJ
267.244 459.261 Td
[(A)-355(s\355ndrome)-411(de)-411(Reye)-411(\(encefalopatia)-412(com)-410(esteatose)]TJ
T*
[(hep\341tica\))-624(est\341)-623(mais)-624(relacionada)-625(ao)-623(emprego)-624(de)]TJ
T*
[(aspirina)-168(em)-167(crian\347as)-167(acometidas)-168(de:)]TJ
0 -24.577 TD
[(A\))-478(varicela.)]TJ
0 -12.288 TD
[(B\))-478(dengue.)]TJ
T*
[(C\))-423(resfriado.)]TJ
T*
[(D\))-423(hepatite)-112(A.)]TJ
T*
[(E\))-478(vacina\347\343o)-168(com)-167(tr\355plice)-167(viral.)]TJ
/T1_0 11 Tf
-277.436 -53.901 Td
(Quest\343o 46)Tj
0 -343.95 TD
(Quest\343o 48)Tj
283.499 366.27 Td
(Quest\343o 50)Tj
ET
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
q 1 0 0 1 777.219 5098.1499 cm
0 0 m
1580.421 0 l
S
Q
Q
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
q 1 0 0 1 777.223 2231.8899 cm
0 0 m
1580.417 0 l
S
Q
Q
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
q 1 0 0 1 3139.71 5284.1401 cm
0 0 m
1580.42 0 l
S
Q
Q
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
q 1 0 0 1 285.465 5157.2002 cm
0 0 m
442.203 0 l
469.457 0 491.754 -22.83 491.754 -50.74 c
491.754 -67.36 l
491.754 -95.27 469.457 -118.11 442.203 -118.11 c
0 -118.11 l
-27.254 -118.11 -49.551 -95.27 -49.551 -67.36 c
-49.551 -50.74 l
-49.551 -22.83 -27.254 0 0 0 c
h
S
Q
Q
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
q 1 0 0 1 285.473 2290.95 cm
0 0 m
442.199 0 l
469.453 0 491.75 -22.84 491.75 -50.75 c
491.75 -67.37 l
491.75 -95.28 469.453 -118.11 442.199 -118.11 c
0 -118.11 l
-27.258 -118.11 -49.555 -95.28 -49.555 -67.37 c
-49.555 -50.75 l
-49.555 -22.84 -27.258 0 0 0 c
h
S
Q
Q
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
q 1 0 0 1 2647.96 5343.1899 cm
0 0 m
442.2 0 l
469.45 0 491.75 -22.83 491.75 -50.74 c
491.75 -67.37 l
491.75 -95.28 469.45 -118.11 442.2 -118.11 c
0 -118.11 l
-27.26 -118.11 -49.55 -95.28 -49.55 -67.37 c
-49.55 -50.74 l
-49.55 -22.83 -27.26 0 0 0 c
h
S
Q
Q
BT
/T1_1 11 Tf
1 0 0 1 28.1494 582.8608 Tm
[(E)-69(m)-903(a)-69(d)-69(u)-69(l)-69(t)-69(o)-69(s)-903(H)-69(I)-69(V)-14(-)-69(p)-69(o)-69(s)-69(i)-69(t)-69(i)-69(v)-69(o)-69(s)-903(a)-903(i)-69(n)-69(c)-69(i)-69(d)-69(\352)-69(n)-69(c)-69(i)-69(a)-903(d)-69(e)]TJ
0 -12.288 TD
[(pneumocistose)-168(associa-se)-168(mais)-167(fortemente:)]TJ
0 -24.577 TD
[(A\))-478(ao)-167(tabagismo.)]TJ
0 -12.288 TD
[(B\))-478(\340)-167(s\355ndrome)-167(metab\363lica.)]TJ
T*
[(C\))-423(\340s)-167(baixas)-167(contagens)-168(de)-167(c\351lulas)-168(CD4+.)]TJ
T*
[(D\))-423(\340s)-167(cargas)-167(virais)-167(maiores)-167(que)-167(100.000)-168(c\363pias/mL.)]TJ
T*
[(E\))-478(\340)-967(c)-133(a)-133(t)-133(e)-133(g)-133(o)-133(r)-133(i)-133(a)-967(d)-133(e)-967(t)-133(r)-133(a)-133(n)-133(s)-133(m)-133(i)-133(s)-133(s)-133(\343)-133(o)-967(d)-133(o)-967(H)-133(I)-133(V)]TJ
16.254 -12.288 Td
[(\(sexual,)-167(transfusional,)-168(vertical)-167(etc\).)]TJ
-16.253 -245.644 Td
[(S)-6(u)-6(r)-6(t)-6(o)-6(s)-840(e)-6(p)-6(i)-6(d)-6(\352)-6(m)-6(i)-6(c)-6(o)-6(s)-840(d)-6(e)-840(c)-6(o)-6(n)-6(j)-6(u)-6(n)-6(t)-6(i)-6(v)-6(i)-6(t)-6(e)-840(h)-6(e)-6(m)-6(o)-6(r)-6(r)-6(\341)-6(g)-6(i)-6(c)-6(a)]TJ
T*
[(aguda)-168(s\343o)-167(mais)-167(frequentemente)-168(associados)-168(a:)]TJ
0 -24.577 TD
[(A\))-478(Rinov\355rus.)]TJ
0 -12.288 TD
[(B\))-5369(.)]TJ
T*
[(C\))-423(Enterov\355rus.)]TJ
T*
[(D\))-423(Influenzav\355rus.)]TJ
T*
[(E\))-6871(.)]TJ
/T1_2 11 Tf
16.254 36.865 Td
(Aspergillus)Tj
0 -36.865 TD
(Pseudomonas)Tj
/T1_1 11 Tf
267.244 452.287 Td
[(Segundo)-374(os)-373(conhecimentos)-374(atuais,)-373(a)-373(ivermectina)-374(\351)]TJ
0 -12.288 TD
[(especialmente)-168(eficaz)-167(nos)-167(casos)-167(de:)]TJ
0 -24.577 TD
[(A\))-478(tricur\355ase.)]TJ
0 -12.288 TD
[(B\))-478(ascarid\355ase.)]TJ
T*
[(C\))-423(enterob\355ase.)]TJ
T*
[(D\))-423(ancilostom\355ase.)]TJ
T*
[(E\))-478(estrongiloid\355ase.)]TJ
ET
q
1 0 0 1 228.125 8.7720337 cm
0 g
/GS1 gs
/Fm0 Do
Q
endstream
endobj
224 0 obj
<>/Subtype/Form/Type/XObject>>stream
1 g
1 0 0 1 0 0 cm
229.625 10.272 m
365.5327 10.272 l
365.5327 22.368 l
229.625 22.368 l
229.625 10.272 l
f
endstream
endobj
104 0 obj
<>
endobj
122 0 obj
<>
endobj
127 0 obj
<>
endobj
128 0 obj
<>
endobj
130 0 obj
<>stream
xWsސˡJ%JgZ(ÔIIBR ӎlٺoiW%u{uXrlKvr1I Ж$tL*fNwgoy%ز%KQvvxEB!ک-